Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F Chapin

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Urology|July 7, 2023
Reply by AuthorsAshesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 26, 2018
Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer HospitalDevin N Patel, Shalini Jha, Lauren E Howard, et al.
Clinical Genitourinary Cancer|November 13, 2015
Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien SystemStephen B Williams, John W Davis, Xuemei Wang, et al.
The Journal of Urology|May 1, 2023
Diagnostic Performance and Safety of <sup>18</sup>F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancerBrian F Chapin, Jenny N Nguyen, Mary F Achim, et al.
BJU International|May 2, 2020
Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillanceDaniel D Shapiro, Justin R Gregg, Amy H Lim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2024
Interreader and Intrareader Reproducibility of <sup>18</sup>F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter StudiesPhillip H Kuo, Giuseppe Esposito, Gary A Ulaner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate CancerChad G Rusthoven, Bernard L Jones, Thomas W Flaig, et al.
Nature Reviews. Urology|April 7, 2021
Optimizing the diagnosis and management of ductal prostate cancerWeranja Ranasinghe, Daniel D Shapiro, Miao Zhang, et al.
Cancer|May 27, 2020
Patterns of metastases of prostatic ductal adenocarcinomaWeranja K B Ranasinghe, Nathan A Brooks, Mohamed A Elsheshtawi, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Urology|July 7, 2023
Reply by AuthorsAshesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 26, 2018
Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer HospitalDevin N Patel, Shalini Jha, Lauren E Howard, et al.
Clinical Genitourinary Cancer|November 13, 2015
Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien SystemStephen B Williams, John W Davis, Xuemei Wang, et al.
The Journal of Urology|May 1, 2023
Diagnostic Performance and Safety of <sup>18</sup>F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancerBrian F Chapin, Jenny N Nguyen, Mary F Achim, et al.
BJU International|May 2, 2020
Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillanceDaniel D Shapiro, Justin R Gregg, Amy H Lim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2024
Interreader and Intrareader Reproducibility of <sup>18</sup>F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter StudiesPhillip H Kuo, Giuseppe Esposito, Gary A Ulaner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate CancerChad G Rusthoven, Bernard L Jones, Thomas W Flaig, et al.
Nature Reviews. Urology|April 7, 2021
Optimizing the diagnosis and management of ductal prostate cancerWeranja Ranasinghe, Daniel D Shapiro, Miao Zhang, et al.
Cancer|May 27, 2020
Patterns of metastases of prostatic ductal adenocarcinomaWeranja K B Ranasinghe, Nathan A Brooks, Mohamed A Elsheshtawi, et al.
Pageof 12